Brand Name: SGONEK
Price: $500 -$560/Kilogram
Place of Origin: Shaanxi, China
Certification: ISO FDA SG COA MSDS
Grade: Feed Grade, Food Grade, Medicine Grade
Payment Terms: T/T, Western Union, MoneyGram
| Product Name: | Gemifioxacin | Cas No.: | 175463-14-6 |
| Molecular Formula: | C18H20FN5O4 | Purity: | 99%min |
| Brand Name: | SGONEK | Certification: | ISO FDA SG COA MSDS |
Product name:Gemifioxacin
CAS NO.:175463-14-6
Synonyms:Gemifioxacin
Category Pharmaceutical Raw Materials Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals.Purity
Appearance:Gemifioxacin powder
Gemifioxacin powder
Shelf life2 years for Gemifioxacin
Usage: Active Pharmaceutical Ingredients
Gemifioxacin is an antibiotic drug.
StorageGemifioxacin should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
|
Analysis |
Specification |
Result |
|
Appearance |
Off white powder |
Complied |
|
Melting range |
260~263°C |
261~262°C |
|
Assay(HPLC) |
≥99% |
99.12% |
|
Mesh size |
80 mesh |
80 mesh |
|
Loss on drying |
≤0.5% |
0.43 |
|
Ignition residue |
≤0.2% |
0.09 |
|
Heavy metals |
≤10ppm |
Conform |
|
Pb |
≤2.0ppm |
0.9ppm |
|
As |
≤2.0ppm |
1.0ppm |
|
Cd |
≤2.0ppm |
0.9ppm |
|
Total plate count |
≤1000cfu/g |
240cfu/g |
|
Yeast and mold |
≤100cfu/g |
19cfu/g |
|
E.coli |
Negative |
Negative |
|
Salmonella |
Negative |
Negative |
|
Pseudomonas aeruginosa |
Negative |
Negative |
|
Aflatoxin B1 |
≤5.0ppm |
Complied |
|
Staphylococus |
Negative |
Negative |
|
Conclusion |
Meets in-house specification. |
|
|
Packing and Storage |
||
|
Packing |
Pack in paper-drums and two plastic-bags inside. |
|
|
Storage |
Store in a well-closed place with constant low temperature and no direct sun light |
|
|
Shelf life |
5 years when properly stored. |
|
Gemifloxacin is a potent new quinolone antibacterial agent that is resistant to methicillin-resistant Staphylococcus aureus and key respiratory pathogens (eg Haemophilus influenzae, Moraxella catarrhalis) compared to other similar drugs. And pneumococcal) has a good effect. According to the in vitro test data, the activity of this product against Streptococcus pneumoniae is stronger than that of ciprofloxacin, sevofloxacin, gepafloxacin and moxifloxacin.
Similar to most quinolones, the effect is to inhibit the synthesis of bacterial cells, inhibit DNA helicase, cause uncontrolled synthesis of mRNA and protein, and cause cells to no longer divide and thus sterilize. Gemifloxacin is a potent new quinolone antibacterial agent that is resistant to methicillin-resistant Staphylococcus aureus and key respiratory pathogens (eg Haemophilus influenzae, Moraxella catarrhalis) compared to other similar drugs. And pneumococcal) has a good effect. According to the in vitro test data, the activity of this product against Streptococcus pneumoniae is stronger than that of ciprofloxacin, sevofloxacin, gepafloxacin, moxifloxacin, etc., and antibacterial against different pneumonia strains resistant to penicillin and erythromycin. The activity is 16 to 64 times higher than that of ciprofloxacin. The lowest MIC90 is 0.03 to 0.06 μg/ml compared to the above drugs. This product shows good results in the infection of anaerobic bacteria.
